Laxmi Organic Industries (LXCHEM) Q4 24/25 earnings summary

Executive summary

• Achieved 11% year-on-year volume growth and 9.4% EBITDA growth, maintaining profitability despite challenging market and geopolitical conditions.

• Growth driven by operational excellence, capacity augmentation, customer-centricity, and prudent cost management.

• Launched Innovation Centre in Navi Mumbai and commenced commercial sales from the fluoro intermediate site in Q4FY25.

• Signed LOI with Hitachi Energy for eco-efficient gas production, entering a new segment in power transmission and generation.

• Board approved annual audited results for FY25 with unmodified audit opinions and recommended a final dividend of Rs. 0.50 per share.

Financial highlights

• FY25 consolidated revenue grew 5% year-on-year to INR 29,854.42 million; standalone revenue at INR 29,446.06 million.

• FY25 EBITDA increased 9% to INR 2,796 million; EBITDA margin at 9.4% (up 41 bps); PAT margin at 3.8%.

• Gross margin for FY25 at 34.8%, up 218-220 bps year-on-year.

• Q4FY25 EBITDA was INR 590 million (adjusted), with Q4 revenue and PAT declining due to one-time items.

• Cash and cash equivalents at FY25 end: INR 416.37 million (consolidated).

Outlook and guidance

• Targeting to double consolidated revenue and triple EBITDA by FY28, with ROCE of 20%.

• Dahej and Lote sites expected to contribute significantly, with commercial production and peak revenues projected in FY26–FY27.

• No equity dilution planned; funding through internal accruals and prudent debt management.

• Minor P&L impact expected in H1 FY26 from regulatory phase-out of a specialty product.

• Board recommended a final dividend and scheduled the 36th AGM for July 31, 2025.